Back to library

KPV

Animal / preclinical

Also known as: Lysine-Proline-Valine

ImmuneAnti-inflammatory / gut (claimed)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

The anti-inflammatory business end of alpha-MSH, distilled to three amino acids. In cell and animal models — particularly colitis models — it damps inflammatory signalling, which is why gut-health protocols have adopted it; human trials are still to come.

Mechanism

Reduces inflammatory signalling (e.g. NF-κB pathways) and shows particular activity in gut epithelium in preclinical models.

Evidence

Animal / preclinicalWhat does this mean?

Consistent preclinical anti-inflammatory data, strongest in gut models; human efficacy trials haven't been run.

Community-reported information

Community reports vary. Anecdotal and unvalidated; general information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short.

Storage

Refrigerate solutions.

Commonly reported side effects

  • Not well characterised in humans

Legal status by region

  • USNot FDA-approved for human use.

Legal status changes over time; verify locally before relying on this.